Ratings by Truist Securities (Supawat Thongthip)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/21/2026 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 10/7/2026 | ArriVent BioPharma | AVBP | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2026 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2026 | Immunome Inc. | IMNM | Maintain | Buy (N/A) |
|
Details | ||
| 6/11/2026 | Sutro Biopharma | STRO | New Coverage | Buy (N/A) |
26.09 (10.79) |
-58.64% | Details | |
| 5/29/2026 | ArriVent BioPharma | AVBP | New Coverage | Buy (N/A) |
26.97 (19.12) |
-29.11% | Details | |
| 5/28/2026 | Immunome Inc. | IMNM | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2026 | Arcus Biosciences | RCUS | New Coverage | Buy (N/A) |
23.78 (19.10) |
-19.68% | Details |
